WUXI BIOLOGICS-00000083
Research WUXI BIOLOGICS-00000083 (1FW2) on Bullrun: market cap EUR 15.30B, P/E 24.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1FW2
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 15.30B
- P/E24.8
- Financial periodFY2024
- RevenueEUR 18.68B
- Revenue growth9.6%
- Net incomeEUR 3.36B
- Free cash flowEUR 1.29B
- Gross margin41.0%
Valuation Snapshot
latest market cap is EUR 15.30B; P/E is 24.8.
About WUXI BIOLOGICS-00000083
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC.
Frequently asked questions
What is WUXI BIOLOGICS-00000083's market cap?
WUXI BIOLOGICS-00000083's market capitalization is EUR 15.30B.
What is WUXI BIOLOGICS-00000083's P/E ratio?
WUXI BIOLOGICS-00000083's price-to-earnings (P/E) ratio is 24.8.
What does WUXI BIOLOGICS-00000083 do?
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.